BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 14754607)

  • 1. Incidence and characteristics of CD4(+)/HLA DRhi dendritic cell malignancies.
    Bueno C; Almeida J; Lucio P; Marco J; Garcia R; de Pablos JM; Parreira A; Ramos F; Ruiz-Cabello F; Suarez-Vilela D; San Miguel JF; Orfao A
    Haematologica; 2004 Jan; 89(1):58-69. PubMed ID: 14754607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: results from the Hellenic Dendritic Cell Leukemia Study Group.
    Tsagarakis NJ; Kentrou NA; Papadimitriou KA; Pagoni M; Kokkini G; Papadaki H; Pappa V; Marinakis T; Anagnostopoulos NI; Vadikolia C; Anagnostopoulos A; Angelopoulou MK; Terpos E; Poziopoulos C; Anargyrou K; Rontogianni D; Papadaki T; Psarra A; Kontopidou FN; Skoumi D; Papadhimitriou SI; Paterakis G;
    Leuk Res; 2010 Apr; 34(4):438-46. PubMed ID: 19793612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+/CD56+ hematodermic neoplasm ("blastic natural killer cell lymphoma"): neoplastic cells express the immature dendritic cell marker BDCA-2 and produce interferon.
    Pilichowska ME; Fleming MD; Pinkus JL; Pinkus GS
    Am J Clin Pathol; 2007 Sep; 128(3):445-53. PubMed ID: 17709319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extensive flow cytometric characterization of plasmacytoid dendritic cell leukemia cells.
    Gopcsa L; Banyai A; Jakab K; Kormos L; Tamaska J; Matolcsy A; Gogolak P; Rajnavolgyi E; Paloczi K
    Eur J Haematol; 2005 Oct; 75(4):346-51. PubMed ID: 16146542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous CD4+ CD56+ hematologic malignancies.
    Magro CM; Porcu P; Schaefer J; Erter JW; Furman RR; Shitabata PK; Crowson AN
    J Am Acad Dermatol; 2010 Aug; 63(2):292-308. PubMed ID: 20541283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The value of multiparameter flow cytometry in diagnosis of lymphocytic leukemia and bone marrow involvement of non-Hodgkin's lymphoma].
    Sun XF; He LR; Feng HL; Yan SL; Xia ZJ; Chen XQ
    Ai Zheng; 2003 Nov; 22(11):1232-6. PubMed ID: 14613660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric immunophenotyping analysis of patterns of antigen expression in non-Hodgkin's B cell lymphoma in samples obtained from different anatomic sites.
    Gervasi F; Lo Verso R; Giambanco C; Cardinale G; Tomaselli C; Pagnucco G
    Ann N Y Acad Sci; 2004 Dec; 1028():457-62. PubMed ID: 15650271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+ CD56+ lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells.
    Jacob MC; Chaperot L; Mossuz P; Feuillard J; Valensi F; Leroux D; Béné MC; Bensa JC; Brière F; Plumas J
    Haematologica; 2003 Aug; 88(8):941-55. PubMed ID: 12935983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia].
    Liu YR; Wang YZ; Chen SS; Chang Y; Fu JY; Li LD; Wang H; Yu H; Jiang B; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):731-6. PubMed ID: 18457262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
    Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R
    Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia.
    Garnache-Ottou F; Feuillard J; Ferrand C; Biichle S; Trimoreau F; Seilles E; Salaun V; Garand R; Lepelley P; Maynadié M; Kuhlein E; Deconinck E; Daliphard S; Chaperot L; Beseggio L; Foisseaud V; Macintyre E; Bene MC; Saas P; Jacob MC;
    Br J Haematol; 2009 Jun; 145(5):624-36. PubMed ID: 19388928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased immature hematopoietic progenitor cells CD34+/CD38dim in myelodysplasia.
    Monreal MB; Pardo ML; Pavlovsky MA; Fernandez I; Corrado CS; Giere I; Sapia S; Pavlovsky S
    Cytometry B Clin Cytom; 2006 Mar; 70(2):63-70. PubMed ID: 16470534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with acute myeloid leukaemia: a methodological approach under serum-free culture conditions.
    Kufner S; Zitzelsberger H; Kroell T; Pelka-Fleischer R; Salem A; de Valle F; Schweiger C; Nuessler V; Schmid C; Kolb HJ; Schmetzer HM
    Scand J Immunol; 2005 Jul; 62(1):86-98. PubMed ID: 16091128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A correlation study of immunophenotypic, cytogenetic, and clinical features of 180 AML patients in China.
    Zheng J; Wang X; Hu Y; Yang J; Liu J; He Y; Gong Q; Yao J; Li X; Du W; Huang S
    Cytometry B Clin Cytom; 2008 Jan; 74(1):25-9. PubMed ID: 18061959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic quantitative features of patients with acute myeloid leukemia.
    Pereira FG; Metze K; Costa FP; Lima CS; Lorand-Metze I
    Neoplasma; 2006; 53(2):155-60. PubMed ID: 16575472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CD4+ CD56+ CD116- CD123+ CD45RA+ CD45RO- profile is specific of DC2 malignancies.
    Trimoreau F; Donnard M; Turlure P; Gachard N; Bordessoule D; Feuillard J
    Haematologica; 2003 Mar; 88(3):ELT10. PubMed ID: 12651292
    [No Abstract]   [Full Text] [Related]  

  • 18. Flow cytometric analysis of circulating dendritic cell subsets and intracellular cytokine production in advanced breast cancer patients.
    Ferrari S; Malugani F; Rovati B; Porta C; Riccardi A; Danova M
    Oncol Rep; 2005 Jul; 14(1):113-20. PubMed ID: 15944777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia.
    Khoury JD; Medeiros LJ; Manning JT; Sulak LE; Bueso-Ramos C; Jones D
    Cancer; 2002 May; 94(9):2401-8. PubMed ID: 12015765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
    Zeleznikova T; Stevulova L; Kovarikova A; Babusikova O
    Neoplasma; 2007; 54(6):471-7. PubMed ID: 17949229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.